Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
Metabolic Brain Disease|May 7, 1998
Post-ischemic alterations in [3H]FK506 binding in the gerbil and rat brainsT Araki, H Kato, K Shuto, et al.Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1984
Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonistK Yamada, K Shuto, K Kubo, et al.European Journal of Pharmacology|October 1, 1998
Alterations in [3H]L-N(G)-nitroarginine binding in brain after transient global or transient focal ischemia in gerbils and ratsT Araki, H Kato, K Shuto, et al.Journal of Pharmacobio-Dynamics|December 1, 1980
Antagonism of KW-5338 (domperidone) against emesis and depression of intestinal motility induced by L-DOPAK Shuto, Z Shiozaki, T Kojima, et al.Journal of Pharmacobio-Dynamics|December 1, 1980
Effects of KW-5338 (domperidone) on gastric motilityK Shuto, S Shiozaki, T Kojima, et al.Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 1, 1994
[Effect of 5-[2-(diethylamino)ethyl]amino-5,11- dihydro[1]benzoxepino[3,4-b]pyridine trihydrochloride (KW-5805) on the biosynthesis of rat gastric mucus]N Kosaka, H Tanaka, A Ishii, et al.Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 1, 1983
[Pharmacological studies on oxatomide: (6) Effect on the peripheral organs]K Ohmori, H Ishii, K Shuto, et al.Thrombosis Research|April 1, 1985
Involvement of disulfide-sulfhydryl interaction in anti-platelet actions of KF4939K Yamada, K Kubo, K Shuto, et al.Japanese Journal of Pharmacology|March 1, 1985
Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulationA Karasawa, K Kubo, K Shuto, et al.The Journal of Pharmacy and Pharmacology|March 1, 1997
Age-related changes in [3H]nimodipine and [3H]rolipram binding in the rat brainT Araki, H Kato, K Shuto, et al.Pageof 10